Cat. No. | Product name | CAS No. |
DC65180 |
DLin-MC2-DMA
Featured
D-Lin-MC2-DMA(MC2) is a cationic lipid that has been synthesized for Lipid nanoparticles (LNPs) to deliver the siRNA. |
1221271-55-1 |
DC65181 |
WAY-299801
Featured
WAY-299801 is an antiacterial agent. WAY-299801 showed interesting in vitro antimycobacterial activity against some strains of Mycobacterium and clin. isolates of M. tuberculosis. |
146430-05-9 |
DC65182 |
DSG-PEG 2000
Featured
DSG-PEG2000 is used for liposome preparation. DSG-PEG, MW 2,000 has become known for lipid nanoparticle (LNP) preparation for siRNA (small interfering RNA) delivery research. . |
308805-39-2 |
DC65183 |
WAY-313013
Featured
WAY-313013 is a p38a Mitogen-Activated Protein Kinase inhibitor. |
326898-76-4 |
DC65184 |
WAY-640810
Featured
WAY-640810 is a chemical agent which may alter the lifespan of a eukaryotic organism. |
851206-31-0 |
DC65185 |
AD-57
Featured
AD-57, also known as KIRA 1, is an IRE1 inhibitor for cancer inflammation autoimmune disease therapy. |
1093380-42-7 |
DC65186 |
DCFH
Featured
DCFH, also known as 2',7'-dichlorodihydrofluorescein, is a fluororescent agent. It is a key chemcial for the dichlorofluorescin (DCFH) oxidation assay. |
106070-31-9 |
DC65187 |
HHS-0701
Featured
HHS-0701, a sulfur-triazole exchange (SuTEx) ligand, is a potent tyrosine-reactive prostaglandin reductase 2 (PTGR2) inhibitor. HHS-0701 blocks PTGR2 metabolism of the lipid substrate 15-Keto-PGE2. |
2851993-91-2 |
DC65188 |
Moracin C
Featured
Moracin C is a phenolic compound isolated from Artocarpus heterophyllus. Moracin C suppresses Lipopolysaccharide-Activated Inflammatory Responses in Murine Raw264.7 Macrophages. |
69120-06-5 |
DC65189 |
BDTX-1535
Featured
BDTX-1535 is a potent, selective, brain penetrant and irreversible MasterKey inhibitor of EGFR mutations that expressed in glioblastoma multiforme (GBM) and intrinsic and acquired resistance EGFR mutations in non-small cell lung cancer (NSCLC). |
2607829-38-7 |
DC65190 |
NSC321039
Featured
NSC321039, also known as hMAO-B-IN-4, is a selective, reversible and blood–brain barrier (BBB) penetrable human monoamine oxidase-B (hMAO-B) inhibitor with an IC50 value of 0.067 μM. |
1666119-75-0 |
DC65191 |
WAY-658513
Featured
WAY-658513 is a multiple kinase inhbitor. WAY658513 was shown to inhibit ROCK I, ERK2, GSK3, and PKA with Ki <1 μM. |
692870-25-0 |
DC65192 |
RXN00442
Featured
RXN00442, also known as EGFR-IN-11, is a fourth-generation EGFR-tyrosine kinase inhibitor (EGFR-TKI). This compound was first reported in Eur J Med Chem. |
2463200-44-2 |
DC65193 |
WAY-299838
Featured
WAY-299838 is a useful chemical agent for chemical synthesis of hypoxia-inducible factor-1 inhibitor. |
333357-56-5 |
DC65194 |
HUN39963
Featured
HUN39963, also known as LDH-IN-2 is an inhibitor of glycolate oxidase. This compound was first reported in J Med Chem. |
893739-96-3 |
DC65195 |
ZVN26391
Featured
ZVN26391, also known as NLRP3-IN-10, is a IL-1β inhibitor for the treatment of inflammation and inflammation-related disease (neurogenic inflammation, Alzheimer disease, etc.). |
2641826-39-1 |
DC65196 |
CUN11141
Featured
CUN11141, also known as BRD4 Inhibitor-20, is a potent orally active bromodomain protein 4 (BRD4) inhibitor. It can be used for the research of kinds of cancer, such as colon cancer. |
2490311-14-1 |
DC65197 |
GSK-3β Inhibitor II
Featured
GSK3β Inhibitor II, also known as KIN 001-042, also known as GSK-3β Inhibitor II, is a GSK-3β inhibitor. |
478482-75-6 |
DC65198 |
VUN28691
Featured
VUN28691, also known as p38α inhibitor 3, is a p38α inhibitor for treatment of p38-α kinase-mediated conditions. |
260428-69-1 |
DC65199 |
1-(4-nitrophenyl)-3-(1-(6-(trifluoromethyl)pyridin-2-yl)piperidin-4-yl)thiourea
Featured
DUN51106, also known as USP8-IN-3, is a deubiquitinase USP8 inhibitor (IC50 = 4.0 μM) for treatment of malignant tumors. |
2477651-10-6 |
DC65200 |
DKI5
Featured
DKI5, also known as (E)-N’-benzylidenehydrazinecarbothiohydrazide, is a LOX-1 inhibitor with an IC50 value of 22.5 μM. DKI5 strongly inhibits lipid peroxidation. |
1101130-96-4 |
DC65201 |
J-3-54
Featured
J 3-54 , also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. VUN34592 can mediate the expression of PD-L1, enhance T cell killing response, and can be used in cancer research. |
4734-59-2 |